ENDRA Life Sciences Bolsters TAEUS® System Intellectual Property with Issuance of 27th U.S. Patent

Author's Avatar
May 25, 2022

ENDRA+Life+Sciences+Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces that the United States Patent & Trademark Office has issued a new patent to ENDRA, U.S. Patent No. 11337676 (the ‘676 patent) titled “Acoustically Compatible Radio-frequency Applicator Method and System.” The ‘676 patent protects ENDRA's method and system for optimizing the delivery of radiofrequency (RF) energy to tissue using TAEUS, and serves as the parent patent for applications being prosecuted in China and in Europe.